Resources

Resources & News

No Results Found

Try adjusting your search to find what you’re looking for.

Asahi Kasei Bioprocess America and GeminiBio enter strategic partnership to advance application of Inline Buffer Formulation and streamline biopharmaceutical manufacturing processes. The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and speed to market. • Costs for biopharmaceutical production can be significantly reduced, positively affecting the accessibility of medication for patients globally. • This partnership will be a catalyst for innovation at both companies, driving new industry standards.
Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, and BroadOak Capital Partners, a life science focused investment firm, announced today the appointment of Bryan Poltilove to the Board of Directors.
Gemini BioProducts Holding, Inc. (“GeminiBio” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Florida-based healthcare private equity firm, announced the appointment of Gopi Natarajan to the Board of Directors.